Evidence map›Paper›PMID 22315232›Full record

ArticleThe Journal of biological chemistry2012

Identification of novel γ-secretase-associated proteins in detergent-resistant membranes from brain.

Ji-Yeun Hur, Yasuhiro Teranishi, Takahiro Kihara, Natsuko Goto Yamamoto, Mitsuhiro Inoue, Waltteri Hosia, Masakazu Hashimoto, Bengt Winblad, Susanne Frykman, Lars O Tjernberg

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Finding New Ways How to Control BACE1.The Journal of membrane biology · 2022
    Article
  5. γ-Secretase in Alzheimer's disease.Experimental & molecular medicine · 2022
    Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Ji-Yeun HurKarolinska Institutet Dainippon Sumitomo Pharma Alzheimer Center, KI Alzheimer Disease Research Center, Department of Neurobiology, Karolinska Institutet, Novum, Huddinge SE-141 57, Sweden. hurj@mskcc.org
Yasuhiro Teranishi
Takahiro Kihara
Natsuko Goto Yamamoto
Mitsuhiro Inoue
Waltteri Hosia
Masakazu Hashimoto
Bengt Winblad
Susanne Frykman
Lars O Tjernberg
Karolinska Institutet · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In Alzheimer disease, oligomeric amyloid β-peptide (Aβ) species lead to synapse loss and neuronal death. γ-Secretase, the transmembrane protease complex that mediates the final catalytic step that liberates Aβ from its precursor protein (APP), has a multitude of substrates, and therapeutics aimed at reducing Aβ production should ideally be specific for APP cleavage. It has been shown that APP can be processed in lipid rafts, and γ-secretase-associated proteins can affect Aβ production. Here, we use a biotinylated inhibitor for affinity purification of γ-secretase and associated proteins and mass spectrometry for identification of the purified proteins, and we identify novel γ-secretase-associated proteins in detergent-resistant membranes from brain. Furthermore, we show by small interfering RNA-mediated knockdown of gene expression that a subset of the γ-secretase-associated proteins, in particular voltage-dependent anion channel 1 (VDAC1) and contactin-associated protein 1 (CNTNAP1), reduced Aβ production (Aβ40 and Aβ42) by around 70%, whereas knockdown of presenilin 1, one of the essential γ-secretase complex components, reduced Aβ production by 50%. Importantly, these proteins had a less pronounced effect on Notch processing. We conclude that VDAC1 and CNTNAP1 associate with γ-secretase in detergent-resistant membranes and affect APP processing and suggest that molecules that interfere with this interaction could be of therapeutic use for Alzheimer disease.

Indexed as

Amino Acid SequenceAmyloid beta-PeptidesAmyloid Precursor Protein SecretasesAnimalsBrainCell Adhesion Molecules, NeuronalChromatography, AffinityGene Knockdown TechniquesHEK293 CellsHumansMaleMembrane GlycoproteinsMembrane MicrodomainsMembrane ProteinsMolecular Sequence DataPeptide FragmentsAmyloid beta-PeptidesAmyloid Precursor Protein SecretasesCell Adhesion Molecules, NeuronalCNTNAP1 protein, humanMembrane GlycoproteinsMembrane Proteinsnicastrin proteinPeptide FragmentsPresenilin-1PSEN1 protein, humanReceptors, NotchSyntaxin 1Tmed10 protein, ratVDAC1 protein, humanVoltage-Dependent Anion Channel 1

Identifiers

PMID22315232
PMCPMC3320946
OpenAlexW2007802800

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.